METHODS: We used ex-vivo bladder afferent recordings to characterise mechanosensitive afferent responses to graded distension (0-60mmHg) and retrograde tracing from the bladder wall to identify central axon projections within the dorsal horn of the lumbosacral spinal cord. Labelling of dorsal horn neurons with phosphorylated-MAP-Kinase (pERK), combined with labelling for neurochemical markers (calbindin, calretinin, GABA, parvalbumin) following in-vivo bladder distension (20-60mmHg) was used to identify spinal cord circuits processing bladder afferent input.
INTRODUCTION AND OBJECTIVES:
Interstitial cystitis and bladder pain (IC/BPS) are chronic conditions that affect 8 million women in the United States. IC/BPS is often co-morbid with depression and anxiety. Majority of the patients report that the stress exacerbates bladder pain and elevated levels of IC symptoms, suggesting interaction between stress and IC. To better understand the interaction between the cystitis induced bladder pain and affective state and stress, we used a mouse model of bladder pain and performed longitudinal studies to characterize the timeline of pain sensitization and negative affective behaviors after induction of the bladder pain and the relationship between stress and bladder pain.
METHODS: We used chemotherapeutic drug cyclophosphamide (CYP) to induce intense bladder inflammation. Measured mechanical sensitivity using von Frey assay, anxiety using elevated zero maze (EZM) and depression using forced swim test (FST).
RESULTS: We observed CYP induced bladder pain in a dose dependent manner. Mice with a dose of 100mg/kg CYP, exhibited significant referred pain sensitization for 1 week and significant anxiety, depressive and anhedonia behavior for 10 days post. Whereas for a dose of 200mg/kg CYP, significant referred pain sensitization was observed for 6 weeks and significant anxiety, depressive and anhedonia behavior for 2 weeks. CYP induced referred pain sensitization dissipated completely 12 weeks post administration. To determine if stress exposure can reinstate the dissipated bladder pain symptoms in previously CYP treated mice, we exposed these mice to acute stress and tested for referred pain sensitization. Acute stress exposure reinstated referred pain sensitivity in the only in CYP treated mice post extinction of pain. Our data suggests acute stress is a potent inducer for emergence of IC/BPS symptoms. CONCLUSIONS: Our data suggests acute stress is a potent inducer for emergence of IC/BPS symptoms. is associated with significant changes in bladder function. We have previously shown that early after SCI there are morphological changes to the rat bladder urothelium (UT), which plays a prominent role in bladder function. Studies have shown that SCI can lead to increased oxidative stress at both cellular and mitochondrial (MITO) levels resulting in tissue damage and functional decline. The objective of this study was designed to provide a comprehensive assessment of MITO alterations including reactive free oxygen (ROS) levels within the bladder UT following acute SCI in mice and whether MITO targeted antioxidant treatment could mitigate these effects.
METHODS: We used female C57 mice (C57Bl/6; 20 gm; 4-5 wks) with complete SCI transection at T9-T10 vertebrae level and collected bladders at 3 days post transection for cell culture, electron microscopy and western immunoblotting. Some animals were treated with the MITO ROS scavenger MitoTempo (mTEM; 1 mg/kg/day delivered by subcutaneous osmotic pump implanted at the time of SCI).
RESULTS: Following acute SCI, we find an increase in MITO morphology with increase in electron dense 'mitobodies' (indicative of cellular damage) which is also supported by an increase (1.25-fold) in the MITO mass marker TOM20. We also find increased (1.3-fold) levels of the autophagy marker light chain 3 (LC3) in SCI. Increased oxidative stress markers nitrotyrosine (2-fold) and ROS (1.6-fold) were also evident as well as increased cleaved caspase 3 (1.5-fold) in SCI versus sham control. These changes were restored with mTEM treatment to that of control or sham levels.
CONCLUSIONS: There are a number of factors that play a role in impaired bladder and UT function after traumatic SCI. Recent evidence has revealed that altered cellular metabolism (i.e., MITO functions) plays an important role. Our study demonstrates that acute traumatic SCI elicits significant changes within UT that involve increased oxidative stress and ROS, and activation of caspases (which play a role in apoptosis). Increased LC3 may be associated with reduction in turnover of autophagosomes-the key structure and system for the degradation of intracellular debris. Strikingly, the dysregulation of this quality control system in SCI is restored by mTEM treatment. Taken together, early treatment with MITO-targeted antioxidant therapy may optimize the management of SCI-bladder dysfunction. 
